We are live on ! Find out more
RCM

Rotella Capital Management Portfolio holdings

AUM $1.47M
1-Year Est. Return 12.32%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
-12.32%
3 Year Est. Return
+26.58%
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
+$3.99M
Cap. Flow
-$1.57M
Cap. Flow %
-1.31%
Top 10 Hldgs %
15.59%
Holding
696
New
328
Increased
91
Reduced
68
Closed
197

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.79%
2 Technology 12.31%
3 Healthcare 10.97%
4 Industrials 7.43%
5 Consumer Staples 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRTX
626
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-5
Closed -$16K
AAIC
627
DELISTED
Arlington Asset Investment Corp.
AAIC
-8,225
Closed -$219K
RAD
628
DELISTED
Rite Aid Corporation
RAD
-7,435
Closed -$1.12M
INFI
629
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-10,300
Closed -$174K
ALBO
630
DELISTED
Albireo Pharma Inc
ALBO
-417
Closed -$17K
BDR
631
DELISTED
Blonder Tongue Laboratories Inc
BDR
-24,400
Closed -$66K
PFBI
632
DELISTED
Premier Financial Bancorp
PFBI
-14,556
Closed -$165K
ALSK
633
DELISTED
Alaska Communications Systems
ALSK
-21,123
Closed -$38K
SMTX
634
DELISTED
SMTC Corporation
SMTX
-11,582
Closed -$20K
APEX
635
DELISTED
Apex Global Brands Inc. Common Stock
APEX
-686
Closed -$399K
TRQ
636
DELISTED
Turquoise Hill Resources Ltd
TRQ
-8,133
Closed -$253K
AXAS
637
DELISTED
Abraxas Petroleum Corp
AXAS
-530
Closed -$31K
DNR
638
DELISTED
Denbury Resources, Inc.
DNR
-14,000
Closed -$114K
PGNX
639
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-36,473
Closed -$276K
SSI
640
DELISTED
Stage Stores Inc
SSI
-16,600
Closed -$344K
DF
641
DELISTED
Dean Foods Company
DF
-11,856
Closed -$230K
TST
642
DELISTED
TheStreet, Inc.
TST
-1,685
Closed -$40K
HZNP
643
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-12,729
Closed -$164K
VXZ
644
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
-4,375
Closed -$230K
SHLD
645
DELISTED
Sears Holding Corporation
SHLD
-9,700
Closed -$320K
AAV
646
DELISTED
Advantage Oil & Gas Ltd
AAV
-18,859
Closed -$90K
ANTH
647
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
-1,941
Closed -$25K
LAYN
648
DELISTED
Layne Christensen Co
LAYN
-69,234
Closed -$660K
SCMP
649
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
-16,798
Closed -$240K
IXYS
650
DELISTED
IXYS Corp
IXYS
-15,450
Closed -$195K

Similar funds

Rotella Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Rotella Capital Management held 696 positions worth $119M, up 3.5% from $115M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Rotella Capital Management's Q1 2015 filing shows 328 new, 91 increased, 68 reduced and 197 closed positions. Its largest new stake was Movado Group: 52,600 shares worth $1.5M. The largest sale was Vanguard Dividend Appreciation ETF, an estimated $3.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

  • Rotella Capital Management's largest Q1 2015 buy was Movado Group: 52,600 shares worth $1.5M.
  • Rotella Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $1.94M increase.
  • Rotella Capital Management's biggest Q1 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $1.77M.
  • Rotella Capital Management fully exited Vanguard Dividend Appreciation ETF in Q1 2015, selling an estimated $3.9M.
  • Rotella Capital Management's ten largest holdings make up 16% of its $119M portfolio in Q1 2015.
  • Rotella Capital Management opened 328 new positions and closed 197 in Q1 2015.
  • Rotella Capital Management's portfolio value rose 3.5% quarter-over-quarter to $119M.

Based on Rotella Capital Management's 13F filing for Q1 2015, filed 4 May 2015.